n(g)-aminoarginine has been researched along with diphenyliodonium in 1 studies
| Studies (n(g)-aminoarginine) | Trials (n(g)-aminoarginine) | Recent Studies (post-2010) (n(g)-aminoarginine) | Studies (diphenyliodonium) | Trials (diphenyliodonium) | Recent Studies (post-2010) (diphenyliodonium) |
|---|---|---|---|---|---|
| 21 | 1 | 2 | 162 | 0 | 48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, A; Cooper, GR; Wolff, DJ | 1 |
1 other study(ies) available for n(g)-aminoarginine and diphenyliodonium
| Article | Year |
|---|---|
Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Topics: Animals; Arginine; Biphenyl Compounds; Cell Line; Cytokines; Enzyme Activation; Enzyme Inhibitors; Mice; Nerve Tissue Proteins; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Onium Compounds; Pituitary Gland; Rats | 1998 |